Immunic, Inc. (IMUX)

NASDAQ

$10,99

$+0,00

(+0,03%)

Pre-Market

Immunic, Inc. (IMUX) Live Price Chart

Last updated: ⁦2026-09-23 12:54:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Immunic, Inc. (IMUX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $10,99, with a market capitalization of $147,77M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5,06 to $17,43. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$147,77M
Open	$10,99
Day's High	$289,90
Day's Low	$5,06
Previous Close	$10,84
Volume	555,00
Average Volume	224,07K
P/E Ratio	--
52-Week High	$17,43
52-Week Low	$5,06
Dividend Yield	--
Earnings Date	--

Immunic, Inc. (IMUX) Pre-Market Stock Price

Immunic, Inc. (IMUX) is trading at $10,99 in pre-market trading as of 2026-09-23 12:52:00, up 1,41% ($0,15) from the previous close of $10,84

Pre-market trading shows how investors are pricing IMUX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Immunic, Inc. (IMUX) 7-Day Stock Price Change

Over the past seven days, Immunic, Inc. (IMUX) moved from $11,23 to $10,99, representing a decline of 2,11% ($0,24).

The stock traded between $10,03 and $11,46 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.

The average daily volume was 378,98 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

IMUX 52-Week Price Position

Position in Range: 48,0%

52W Low$5,06

52W High$17,43

IMUX is currently trading at $10,99, placing it 48,0% of the way from its 52-week low of $5,06 to its 52-week high of $17,43. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Immunic, Inc. (IMUX)?

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

Immunic, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	95
Exchange	NASDAQ
Company Website	https://www.imux.com

How to Buy Immunic, Inc. (IMUX) Stock on MEXC

Eligible investors can buy real shares of Immunic, Inc. (IMUX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for IMUX and Place Your Order

Open the RealStocks trading page and search for IMUX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Immunic, Inc. (IMUX) stock price today?

Immunic, Inc. (IMUX) is currently trading at $ 10,99, up 1,41% ($0,15) from the previous close of $ 10,84. Intraday prices update in real time during regular trading hours.

2.Is IMUX stock going up or down today?

As of 2026-09-23 12:52:00, IMUX is trading at $ 10,99, up 1,41% ($0,15) from its previous close of $ 10,84. The stock has traded between $ 5,06 and $ 289,90 during today’s regular session. Past price movements do not guarantee future results.

3.What is IMUX pre-market price?

As of 2026-09-23 12:52:00, IMUX is trading at $ 10,99 in pre-market trading, up 1,41% ($0,15) from the previous close of $ 10,84. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is IMUX after-hours price?

As of 2026-09-23 12:52:00, IMUX is trading at $ 10,99 in after-hours trading, up 1,37% ($0,15) from the regular-session close of $ 10,84. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is IMUX stock trading now?

IMUX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does IMUX sit relative to its 52-week high and low?

Over the past 52 weeks, IMUX has traded between a low of $ 5,06 and a high of $ 17,43. At $ 10,99, the stock is positioned 48,0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Immunic, Inc. in?

Immunic, Inc. (IMUX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Immunic, Inc.'s market capitalization and where is it listed?

Immunic, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 147,77M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is IMUX valued in terms of P/E ratio and EPS?

IMUX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -8,18. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Immunic, Inc. pay a dividend?

Immunic, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.